1672 — Ascletis Pharma Cashflow Statement
0.000.00%
- HK$1.09bn
- -HK$1.37bn
- CNY56.60m
- 31
- 25
- 17
- 10
Annual cashflow statement for Ascletis Pharma, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -96 | -209 | -199 | -315 | -145 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -55.9 | 29.1 | 8.31 | 82.8 | -132 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 55.3 | 68 | 14.2 | 59.4 | 114 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -74.3 | -84.9 | -147 | -142 | -144 |
Capital Expenditures | -28.2 | -39 | -7.2 | -14.4 | -19.2 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 631 | 171 | -267 | -1,283 | 169 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 602 | 132 | -274 | -1,297 | 150 |
Financing Cash Flow Items | 0 | — | -0.125 | -0.157 | -0.144 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -48.2 | -21.7 | -31.1 | -1.42 | -81.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 513 | -84.5 | -483 | -1,324 | -73.7 |